HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Ornithine Decarboxylase Inhibitors

Substances and drugs that inhibit or block the activity of ORNITHINE DECARBOXYLASE.

Also Known As:

Decarboxylase Inhibitors, Ornithine; Inhibitors, Ornithine Decarboxylase

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Chemical Actions and Uses
- Pharmacologic Actions: 160
  - Molecular Mechanisms of Pharmacological Action: 24
    - Enzyme Inhibitors: 1659
      - Ornithine Decarboxylase Inhibitors: 4

Experts

1.	Luqman, Suaib: 1 article (01/2012)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2012 - "Future exploration of ornithine decarboxylase inhibitors present in nature may offer great hope for finding new cancer chemopreventive agents."
2.	Visceral Leishmaniasis (Kala Azar) 01/01/2023 - "Drug repositioning to discover novel ornithine decarboxylase inhibitors against visceral leishmaniasis."
3.	Infections 01/01/1987 - "Two ornithine decarboxylase inhibitors, DL-alpha-difluoromethylornithine (eflornithine; DFMO) and a-monofluoromethyldehydroornithine methyl ester (delta MFMO X CH3) were compared in their ability to cure two distinct Trypanosoma brucei brucei central nervous system murine model infections. "
4.	Fetal Growth Retardation (Intrauterine Growth Retardation) 10/01/1983 - "Ornithine decarboxylase inhibitors and fetal growth retardation in mice."

Related Drugs and Biologics

1.	Esters
2.	Eflornithine (Ornidyl)